Biofilms of Staphylococcus epidermidis and Candida spp. are two of the most frequent factors of infections associated with the use of indwelling medical devices. Several strategies have been proposed and/or developed to prevent infection. The aim of this study was to compare the effect of sub-inhibitory concentrations of anti-microbial agents on biofilm formation. Biofilms of three strains of S. epidermidis and two of both Candida albicans and Candida dubliniensis were formed in the presence of three antibiotics and two antifungal agents respectively. Based on the control samples, the percentage of biofilm formation inhibition by the different agents was determined and compared. The results showed that the influence of the antibacterial and antifungal agents tested is strain dependent, with the effect of the different agents also varying among strains, even though they have the same mechanism of action. (Int J Artif Organs 2005; 28: 1181-5) 
INTRODUCTION
In order to invade and infect the human body microorganisms need to form resistant and strong structures -biofilms. Biofilm structures comprise a heterogeneous mosaic that is characterized by a basal layer and stacks of microcolonies extending up into the aqueous phase; a porous biofilm with mushroom-like structures dispersed with water channels; and a denseconfluent biofilm that appears more tightly packed, often containing multiple species of microorganisms with regions of lower density that may act as transpor t channels within the biofilm (1) . Whatever the structure, the microbial cells are always embedded into an extracellular polymeric matrix. The role of the biofilm is to resist the cleansing action of fluids, which is a mechanism of defence at various anatomical sites, and also acting as a reservoir for nutrients.
Severe problems related to biofilm formation on indwelling medical devices have been reported (2, 3) , including dysfunction of the implanted device to lethal sepsis of the patient. The eradication of a biofilm is a complicated issue because microorganisms in a biofilm are more resistant to antimicrobial agents than their planktonic counterparts (4) .
Most human body colonizers are bacteria, however some yeast infections are also found. These microorganisms can colonize either the human cells or indwelling devices, the latter being one of the greatest problems as their use is increasing.
Staphylococcus epidermidis and related coagulasenegative staphylococci (CoNS) are now considered among the major nosocomial pathogens associated with the use of indwelling medical devices and their ability to
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Candida albicans and Candida dubliniensis are two pathogenic yeasts that are well known for colonization of the oral cavity and prosthetic devices and are responsible for Candidiasis which can be fatal in immunosupressed individuals.
A successful clinical response to therapy typically not only depends on the susceptibility of the pathogenic organism but also relies heavily on the host immune system, drug penetration and distribution, patient compliance and absence of a protected or persistent focus of infection. Microbial resistance of a given pathogen must be regarded as a quantifiable variable, determined by measurement of drug susceptibility and must be defined with respect to a reference population (6) . This quantifiable variable can be the minimal inhibitory concentration (MIC), which is the lowest drug concentration that avoids visible growth of the microbial pathogen.
The use of antimicrobial agents has been much studied in recent years. Several therapies have been developed to improve the results obtained with the normal therapies (antimicrobial uses in single doses), as controlled release of drugs using coated polymers (7) . Occasionally, as for example in immunosupressed individuals, drugs must be applied in longer treatments in order to prevent any infection. In this case, the dose of these agents is typically low, which may result in blood levels that are either clinically subinhibitory or less than the in vitro MIC (8) . The exposure of patients to subinhibitory concentrations of antimicrobial agents may induce various changes in bacterial and yeast properties, including morphological or ultrastructural changes and inhibition or stimulation of enzyme and toxin production (8, 9) .
In the mouth, the diluent effect of saliva and the cleansing action of the oral musculature often tend to reduce the viability of the agents to below that of the effective therapeutic concentration (10) . Thus, microbial cells in the oral cavity experience only a limited exposure to the antimicrobial agent during treatment and the concentration of the drug may vary in different niches of the mouth (11) .
One of the main goals of the present work was the comparison of the influence of subinhibitory concentrations of antimicrobial agents in the formation of biofilms by two distinct types of microorganisms, Staphylococcus epidermidis and Candida species.
MATERIALS AND METHODS

Bacteria
Growing conditions Three S. epidermidis strains were used, S. epidermidis 9142 is a known producer of the major surface polysaccharide promoting CoNS adherence and biofilm formation, poly-N-acetylglucosamine (PNAG); S. epidermidis IE186 was isolated from infective endocarditis patients; and S. epidermidis M187 was isolated from patients with peritonitis associated with renal dialysis. The strains were kindly provided by Dr. G.B. Pier from the Harvard Medical School, Boston, USA.
Tryptic soy broth (TSB) and tryptic soy agar (TSA) were prepared according to the manufacturer's instructions. All strains were inoculated into 15 mL of TSB from TSA plates no older than 2 days. Liquid cultures were grown for 24 (±2) h at 37°C in an orbital shaker at 130 rpm. The cells were harvested by centrifugation (for 5 min at 10000 rpm at 4ºC), then washed and resuspended in a saline solution (0.9% NaCl prepared in distilled water) to an optical density equivalent to 1 x 10 9 cells ml -1 .
Antibiotics
The antibiotics used in this study were cefazolin, vancomycin and dicloxacillin, which act as inhibitors of cell wall synthesis and are routinely used to treat staphylococcal infections (12, 13) . The sub-MIC used was 1/2 of the lowest MIC value (14) .
Biofilm formation
Formation of bacterial biofilms was performed as described previously (15) . Briefly, sterilized acrylic squares were placed in 6-well tissue culture plates containing 6 mL of TSB supplemented with 0.25% glucose and the respective amount of antibiotic. Then 200 µL of a 0.9% NaCl solution containing 1 x 10 9 cells ml -1 were added and growth was allowed to occur for 48 h at 37ºC in a shaker at 120 rpm. Every 8 h the TSB medium containing suspended bacterial cells was removed and an equal volume of fresh TSB with 0.25% glucose and antibiotic was added. Negative controls were obtained by incubating the surfaces in TSB supplemented with 0.25% glucose and antibiotics without adding any bacterial cells. All experiments were done in quadruplicate with three repeats.
Biofilm quantification
Bacterial biofilms were quantified by dr y-weight determinations, as previously described (16) with some modifications. Briefly, the colonized acrylic surfaces were removed from the plates and placed at 80ºC overnight. Then the weight of the surface was determined on a digital scale. Surfaces were placed again at 80ºC for 2 more hours and weighed again, to check the stability of the dry weight. Then, the biofilm was mechanically removed from the surface, and the surfaces were thoroughly cleaned with 0.2% commercial detergent solution. Cleaned surfaces were kept overnight at 80ºC prior to a third weight determination. The difference in the weight of the surface with and without the biomass attached is the biofilm dryweight.
Yeasts
Yeast growing conditions
Two strains of Candida albicans and two strains of Candida dubliniensis were used in this study. In the case of Candida albicans one strain was from the American Type Culture Collection, ATCC 32354 (Candida albicans B311) and the other was a clinical isolate (Candida albicans 12A), kindly provided by the Biology Department, University of Minho, Portugal. In the case of Candida dubliniensis, the two strains were obtained from Centraalbureau voor Schimmelcultures, the Netherlands, CBS (Candida dubliniensis 7987 and Candida dubliniensis 7988).
Yeast cells were grown for 24 h in SDA at 37ºC, for all the assays. The cells were then inoculated in SDB for 18 h at 37 ºC and 150 rpm. After this, 10 8 cell ml -1 were diluted 1:10 in artificial saliva growth medium, used as control and in the same medium supplemented with subinhibitory concentrations of both antifungal agents. Cells were grown in these media for 24 h at 37 ºC and 150 rpm. The cells were then harvested by centrifugation for 10 min at 5000 rpm at 4 ºC and washed twice with ultrapure sterile water. Saliva growth medium was prepared supplementing artificial saliva (in mg l -1 : 125. 6 
Antifungal agents
The antifungal agents used were: fluconazole (Pentafarma) and amphotericin B (ICN). Fluconazole was diluted in water until a subinhibitory concentration (1/2 MIC) of 0.25 µg ml -1 . In the case of amphotericin B, the first dilution was in DMSO, once it is not water soluble, and the further dilutions were made in water to reach a subinhibitory concentration of 0.01 µg ml -1 . The antifungal solutions were prepared immediately before each experiment.
Biofilm formation
The biofilms were formed on acrylic coupons (8 x 8 mm 2 ), that were prepared as described previously (17) and placed in the bottom of 24 well microtiter plates. An inoculum of 2 mL yeast cell suspension (10 7 cell ml -1 ) was added to each well and biofilm was formed in artificial saliva growth medium with and without fluconazole and amphotericin B. The media were changed each 12 h and the biofilms analysed after 78 h of formation. The experiments were performed in triplicate and repeated twice.
Biofilm quantification
After biofilm formation, the coupons were removed from each well and immersed in a new microtiter plate containing 1 mL of methanol in each well. Methanol was withdrawn after 15 min of contact and the coupons were allowed to dry at room temperature. After that, 600 µL of crystal violet were added to each well and incubated for 5 min. The coupons were then gently washed in water and immersed in 1 mL of acetic acid (33%) to release and dissolve the stain. The absorbance of the obtained solution was read at 570 nm.
RESULTS AND DISCUSSION
To accomplish the comparison of the influence of subinhibitory conditions of antimicrobial agents on the formation of biofilms by yeasts and bacteria, the pathogenic strains and abiotic surfaces were chosen to be closely related with typical sites of infection. Although acr ylic was used in both assays, concerning S. epidermidis the acrylic used was similar to the one used in some indwelling devices, whereas self-polymerised acrylic common in oral prosthetic devices was used with Candida species. Biofilms were quantified after 48 h for bacteria and after 78 h for yeasts. This difference is due to the time needed to achieve mature biofilms.
The assessment of the effect of subinhibitory concentrations of both antibacterial and antifungal agents in biofilm formation was determined by the percentage of inhibition of biofilm formation (Tabs. I and II).
The effect of sub-inhibitor y concentrations of vancomycin on biofilm formation by all the strains of S. epidermidis was the lowest compared to the other two antibiotics used (Tab. I).
It is interesting to note that for both antifungal agents the inhibition was higher in the biofilms formed by Candida dubliniensis strains (Tab. II). When amphotericin B was used the highest effect was on Candida dubliniensis 7987, showing that this strain presents a different behavior compared to the other Candida dubliniensis strain. The opposite happened in the presence of subMIC of fluconazole, both strains of Candida dubliniensis presented similar reductions on the biofilm amounts, but Candida albicans 12A had a low inhibition than Candida albicans B311.
These differences among strains were also present in bacterial biofilms, since the percentage of inhibition obtained with the different antibiotics was not similar for the three CoNS assayed (Tab. I) and it should be emphasized that they all have the same mechanism of action, being cell wall synthesis inhibitors. Moreover, each antibiotic had a different effect on biofilm inhibition according to the strain targeted. This is a very important issue since almost all the studies on the effect of antimicrobial agents in both bacteria and yeast biofilms tend to generalize the behavior of a species without taking strain differences into consideration. It is also very interesting to note that the effect of the different antimicrobial agents varies depending on the strain. For instance, amphotericin B is a fungicidal agent while fluconazole is fungistatic, but they act differently against the two strains of the two species.
A special remark is due on the method used for biofilm formation. In the present work, both bacteria and yeast biofilms were formed in a fed-batch system in order to avoid the lack of nutrients (18) . The type of biofilm formation, static or dynamic can considerably affect the results obtained since the formation of new phenotypes that could subvert the inhibitory effect of the antimicrobial agents can occur when there is no lack of nutrients (19) . On the contrary, static model systems may not provide sufficient time for a biofilm variant to develop and the results can be biased.
CONCLUSIONS
The main general conclusion of this study is that the effect of sub-inhibitory concentrations of anti-microbial agents is dependent on the microorganism at a strain level and on the type of drug, even for drugs having the same mechanism of action.
If biofilm formation is inhibited by subMIC of an antimicrobial agent, the subsequent clinical results are also affected. In this way, the anti-biofilm effect of a drug may be relevant in assessing the selection of anti-microbial treatment. On the other hand, the failure of a prophylactic strategy based on the administration of subMIC of antimicrobial agents may have important clinical implications, threatening the eradication of the infection and favoring increased resistance against the antimicrobial agent. 
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